Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

NovoCure Limited - Ordinary Sha (NVCR)

18.10 0 (+0.00%)

10/23/2017  4:00pm

Open:

18.25

Pre. Close:

18.10

High:

18.62

Low:

18.10

Volume:

403,585

Market Cap:

1.61B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

18.94 - 19.26

19.26 - 19.76

Low:

17.42 - 17.62

17.62 - 17.91

Close:

17.58 - 18.08

18.08 - 18.84

Technical analysis  (as of: 2017-10-23 4:43:48 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 23.14     One year: 25.81

Support:

Support1: 16.10    Support2: 13.40

Resistance:

Resistance1: 19.81    Resistance2: 22.10

Pivot:

18.29

Moving Averages:

MA(5): 18.14     MA(20): 18.83

MA(100): 18.60     MA(250): 12.67

MACD:

MACD(12,26): -0.59     Signal(12,26,9): -0.57

%K %D:

%K(14,3): 44.95     %D(3): 43.15

RSI:

RSI(14): 43.32

52-Week:

High: 22.30  Low: 5.95  Change(%): 173.4

Average Vol(K):

3-Month: 87209  10-Days 73040

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
NVCR has closed above bottom band by 44.3%. Bollinger Bands are 0.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 13 Oct 2017 21:18:27 GMT
NovoCure Ltd is Now Oversold

Mon, 03 Apr 2017 17:06:56 GMT
Here's Why NovoCure Ltd. Is Skyrocketing Today

Wed, 02 Sep 2015 05:14:13 GMT
18.10

Mon, 23 Oct 2017 11:37:30 GMT
Jim Cramer Gives His Opinion On Novocure, Barnes & Noble And PACCAR

Thu, 28 Jul 2016 20:22:19 GMT
Why Novocure Ltd Is Plunging Today

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

88.00

Shares Float (M)

58.69

% Held by Insiders

23.36

% Held by Institutions

49.70

Shares Short (K)

7010

Shares Short Prior Month (K)

7150

Stock Financials

EPS

-1.090

EPS Est. Current Year

-0.770

EPS Est. Next Year

-0.080

EPS Est. Next Quarter

-0.160

Forward EPS

-0.080

Book Value (p.s.)

1.330

PEG Ratio

-0.39

Profit Margin

-75.91

Operating Margin

-59.93

Return on Assets (ttm)

-18.5

Return on Equity (ttm)

-62.5

Qtrly Rev. Growth

114.2

Gross Profit (p.s.)

0.483

Sales Per Share

1.422

EBITDA (p.s.)

-0.786

Qtrly Earnings Growth

Operating Cash Flow (M)

-80.00

Levered Free Cash Flow (M)

-52.37

FoxReading.com

Valuation

P/E

-16.61

P/E Growth Ratio

P/BV

13.61

P/S

12.73

P/CF

-19.91

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.